Company News »

Anika Therapeutics to Present at Jefferies 2015 Global Healthcare Conference on June 4

Business Wire
Share on StockTwits
Published on

Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that its President and Chief Executive Officer, Charles H. Sherwood, Ph.D., will make a presentation at the Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 at 1:30 p.m. ET. The conference is being held at the Grand Hyatt hotel in New York City.

A live audio webcast of the presentation may be accessed via the “Investor Relations” section of Anika’s website at An audio archive of the presentation also will be available on the website.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika’s products range from orthopedic/joint health solutions led by Orthovisc and Monovisc, treatments for osteoarthritis, to surgical aids in the anti-adhesion and ophthalmic fields. The Company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika’s Italian subsidiary, Anika Therapeutics S.r.l., provides complementary HA products in the orthopedic/joint health and anti-adhesion fields, as well as therapeutics in areas such as advanced wound treatment and ear, nose, and throat care. Its regenerative technology advances Anika’s vision to offer therapeutic products and medical solutions that go beyond pain relief to protect and restore damaged tissue.

Share on StockTwits